So sánh phương pháp
Xem các phương pháp đã chọn cạnh nhau; những hàng khác biệt được làm nổi bật.
| Điểm CHA₂DS₂-VASc× | Thang điểm Wells cho DVT× | |
|---|---|---|
| Lĩnh vực | Đánh giá lâm sàng | Đánh giá lâm sàng |
| Họ | Process / pipeline | Process / pipeline |
| Năm ra đời≠ | 2010 | 1994 |
| Người khởi xướng≠ | Gregory Y. H. Lip, Robby Nieuwlaat, et al. | Philip S. Wells |
| Loại≠ | Atrial fibrillation stroke risk stratification | Venous thromboembolism risk stratification |
| Công trình gốc≠ | Lip, G. Y., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. (2010). Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest, 137(2), 263-272. DOI ↗ | Wells, P. S., Hirsh, J., Anderson, D. R., et al. (1994). A simple clinical model for the diagnosis of deep-vein thrombosis combined with impedance plethysmography. Archives of Internal Medicine, 154(13), 1541-1546. link ↗ |
| Tên gọi khác | CHA2DS2VASc, Atrial fibrillation stroke risk | Wells DVT Score, DVT Wells |
| Liên quan | 3 | 3 |
| Tóm tắt≠ | The CHA₂DS₂-VASc score, developed by Lip, Nieuwlaat, and colleagues in 2010, is a 9-point risk stratification tool for predicting annual stroke and systemic thromboembolism risk in patients with atrial fibrillation. It is the recommended score by major cardiology guidelines for guiding anticoagulation decisions. | The Wells score, developed by Wells et al. in 1994, is a clinical prediction rule that stratifies patients into low, intermediate, or high pretest probability of deep vein thrombosis (DVT). It combines seven clinical features to guide diagnostic testing decisions and reduce unnecessary imaging in suspected DVT patients. |
| ScholarGateBộ dữ liệu ↗ |
|
|